313 related articles for article (PubMed ID: 1164816)
1. Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.
Vesell ES; Passananti GT; Glenwright PA; Dvorchik BH
Clin Pharmacol Ther; 1975 Sep; 18(3):259-72. PubMed ID: 1164816
[TBL] [Abstract][Full Text] [Related]
2. Interaction between antipyrine and aminopyrine.
Vesell ES; Passananti GT; Hepner GW
Clin Pharmacol Ther; 1976 Dec; 20(6):661-9. PubMed ID: 991537
[TBL] [Abstract][Full Text] [Related]
3. Aminopyrine disposition: studies on breath, saliva, and urine of normal subjects and patients with liver disease.
Hepner GW; Vesell ES
Clin Pharmacol Ther; 1976 Dec; 20(6):654-60. PubMed ID: 991536
[TBL] [Abstract][Full Text] [Related]
4. Benzo(a)pyrene metabolism and plasma elimination rates of phenacetin, acetanilide and theophylline in man.
Kellermann G; Luyten-Kellermann M
Pharmacology; 1978; 17(4):191-200. PubMed ID: 693568
[TBL] [Abstract][Full Text] [Related]
5. A sensitive gas-chromatographic assay using a nitrogen-phosphorus detector for determination of antipyrine and aminopyrine in biological fluids.
Shively CA; Simons RJ; Vesell ES
Pharmacology; 1979; 19(5):228-36. PubMed ID: 538077
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of antipyrine pharmacokinetics in saliva and plasma using a colourimetric method of antipyrine analysis.
Harman AE; Priestly BG; Frewin DB
Clin Exp Pharmacol Physiol; 1977; 4(6):593-6. PubMed ID: 589875
[TBL] [Abstract][Full Text] [Related]
7. Saliva and plasma clearance of antipyrine as reflectors of liver function.
Luoma PV; Sotaniemi EA
Eur J Drug Metab Pharmacokinet; 1981; 6(4):261-4. PubMed ID: 7333326
[TBL] [Abstract][Full Text] [Related]
8. Dietary influences on the kinetics of antipyrine and aminopyrine in human subjects.
Krishnaswamy K; Kalamegham R; Naidu NA
Br J Clin Pharmacol; 1984 Feb; 17(2):139-46. PubMed ID: 6704283
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the half-life of antipyrine in plasma, whole blood and saliva of man.
van Boxtel CJ; Wilson JT; Lindgren S; Sjöqvist F
Eur J Clin Pharmacol; 1976 Feb; 9(4):327-32. PubMed ID: 971716
[TBL] [Abstract][Full Text] [Related]
10. Diurnal rhythms of aminopyrine metabolism: failure to sleep deprivation to affect them.
Poley GE; Shively CA; Vesell ES
Clin Pharmacol Ther; 1978 Dec; 24(6):726-32. PubMed ID: 568534
[TBL] [Abstract][Full Text] [Related]
11. The effect of fenfluramine on disposition and rate of antipyrine elimination.
O'Malley K; Stevenson IH; West M
Pharmacology; 1975; 13(1):12-9. PubMed ID: 1153500
[TBL] [Abstract][Full Text] [Related]
12. Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.
Danhof M; van Zuilen A; Boeijinga JK; Breimer DD
Eur J Clin Pharmacol; 1982; 21(5):433-41. PubMed ID: 7075648
[TBL] [Abstract][Full Text] [Related]
13. Elimination of antipyrine from saliva as a measure of metabolism in man.
Welch RM; DeAngelis RL; Wingfield M; Farmer TW
Clin Pharmacol Ther; 1975 Sep; 18(3):249-58. PubMed ID: 1164815
[TBL] [Abstract][Full Text] [Related]
14. Quinine-induced alterations in drug disposition.
Berlin CM; Stackman JM; Vesell ES
Clin Pharmacol Ther; 1975 Dec; 18(6):670-9. PubMed ID: 1204275
[TBL] [Abstract][Full Text] [Related]
15. Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism.
Døssing M; Pilsgaard H; Rasmussen B; Poulsen HE
Eur J Clin Pharmacol; 1983; 25(2):215-22. PubMed ID: 6628504
[TBL] [Abstract][Full Text] [Related]
16. Disposition of aminopyrine, antipyrine, diazepam, and indocyanine green in patients with liver disease or on anticonvulsant drug therapy: diazepam breath test and correlations in drug elimination.
Hepner GW; Vesell ES; Lipton A; Harvey HA; Wilkinson GR; Schenker S
J Lab Clin Med; 1977 Sep; 90(3):440-56. PubMed ID: 894100
[No Abstract] [Full Text] [Related]
17. The disposition of antipyrine and its metabolites in young and elderly healthy volunteers.
Posner J; Danhof M; Teunissen MW; Breimer DD; Whiteman PD
Br J Clin Pharmacol; 1987 Jul; 24(1):51-5. PubMed ID: 3620285
[TBL] [Abstract][Full Text] [Related]
18. Assessment of antipyrine kinetics by measurement in saliva.
Fraser HS; Mucklow JC; Murray S; Davies DS
Br J Clin Pharmacol; 1976 Apr; 3(2):321-5. PubMed ID: 973966
[TBL] [Abstract][Full Text] [Related]
19. A non-invasive method for the study of hepatic drug metabolism in rodents: antineoplastic drug effects on antipyrine metabolism in mice.
Wilson VL; Larson RE; Moldowan MJ
Chem Biol Interact; 1982 Jun; 40(2):159-68. PubMed ID: 7083391
[TBL] [Abstract][Full Text] [Related]
20. [Studies on the combination of drugs. VI. Effect of 4-hydroxyantipyrine etheral derivatives on metabolism of aminopyrine, phenacetin, acetanilide, and phenylbutazone].
Nakayama T
Yakugaku Zasshi; 1968 Jul; 88(7):847-51. PubMed ID: 5750525
[No Abstract] [Full Text] [Related]
[Next] [New Search]
